Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00654329 · ClinicalTrials.gov registry record · Phase 4
Dexmedetomidine vs Fentanyl for BMT
A Phase 4 study, sponsored by Children's National Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 101
- Enrollment target
NCT00654329 is a Phase 4 study that has completed, run by Children's National Research Institute. The registered enrollment target is 101 participants.
The verdict
NCT00654329, a Phase 4 study, has completed, sponsored by Children's National Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 101 participants
- Enrollment target
Study Summary
A randomized controlled clinical trial to examine effects of intranasal dexmedetomidine, an α2-adrenorecptor agonist, on pain control and agitation in children undergoing BMT.
Interventions
- DRUG Saline
- DRUG Dexmedetomidine
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00654329
The ClinicalTrials.gov registry entry for NCT00654329 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Saline is the first listed.
NCT00654329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00654329 about?
NCT00654329 is a clinical study titled "Dexmedetomidine vs Fentanyl for BMT". A randomized controlled clinical trial to examine effects of intranasal dexmedetomidine, an α2-adrenorecptor agonist, on pain control and agitation in children undergoing BMT.
What is the current status of trial NCT00654329?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 101 participants. The study started on 2005-08. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00654329?
The interventions under investigation include: Saline (DRUG), Dexmedetomidine (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT00654329?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.